CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 65 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,225 | +142.0% | 12,040 | +266.1% | 0.00% | – |
| Q4 2022 | $2,159 | -28.0% | 3,289 | -3.2% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 3,398 | -35.3% | 0.00% | – |
| Q2 2022 | $3,000 | -93.0% | 5,251 | -86.6% | 0.00% | – |
| Q1 2022 | $43,000 | -65.6% | 39,185 | -46.2% | 0.00% | – |
| Q4 2021 | $125,000 | -45.4% | 72,865 | -2.2% | 0.00% | – |
| Q3 2021 | $229,000 | -16.4% | 74,508 | +6.2% | 0.00% | – |
| Q2 2021 | $274,000 | +161.0% | 70,155 | +85.7% | 0.00% | – |
| Q1 2021 | $105,000 | -91.7% | 37,781 | -90.9% | 0.00% | – |
| Q4 2020 | $1,264,000 | +233.5% | 413,156 | +562.5% | 0.00% | – |
| Q3 2020 | $379,000 | +689.6% | 62,364 | +672.0% | 0.00% | – |
| Q2 2020 | $48,000 | +585.7% | 8,078 | +190.5% | 0.00% | – |
| Q1 2020 | $7,000 | -92.1% | 2,781 | -91.6% | 0.00% | – |
| Q4 2019 | $89,000 | -26.4% | 33,188 | +232.6% | 0.00% | – |
| Q3 2019 | $121,000 | +384.0% | 9,978 | +338.4% | 0.00% | – |
| Q2 2019 | $25,000 | – | 2,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |